Exact Sciences (EXAS) Tops Q1 EPS by 32c; raises guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Net loss per share-basic and diluted (in dollars per share): -0.36
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.42), $0.32 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $602.45 million versus the consensus estimate of $543.29 million.
GUIDANCE:
Exact Sciences sees FY2023 revenue of $2.38-2.42 billion, versus the consensus of $2.299 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- Alcoa closes $2.6B debt offering to fund South32 asset acquisition
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
